Transforming growth factor-beta1 and incident type 2 diabetes: results from the MONICA/KORA case-cohort study, 1984-2002.
about
Getting 'Smad' about obesity and diabetesAssociation between traffic-related air pollution, subclinical inflammation and impaired glucose metabolism: results from the SALIA studyThe extracellular matrix protein MAGP1 supports thermogenesis and protects against obesity and diabetes through regulation of TGF-βImmunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study.Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function.Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions.The role of the polycystic ovary syndrome susceptibility locus D19S884 allele 8 in maternal glycemia and fetal sizeReplication analysis for severe diabetic retinopathy.Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits.TGF-β and restenosis revisited: a Smad link.Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes.Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetesMAGP1, the extracellular matrix, and metabolism.IMMUNOLOGICAL EVALUATION OF PATIENTS WITH TYPE 2 DIABETES MELLITUS SUBMITTED TO METABOLIC SURGERYN-Acetylcysteine effects on transforming growth factor-β and tumor necrosis factor-α serum levels as pro-fibrotic and inflammatory biomarkers in patients following ST-segment elevation myocardial infarction.Changes of Regulatory T Cells and of Proinflammatory and Immunosuppressive Cytokines in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Antipsychotics activate the TGFβ pathway effector SMAD3Morphogenetics in brown, beige and white fat development.Secretory leukocyte protease inhibitor promising protective roles in obesity-associated atherosclerosis.Characterization of metabolic health in mouse models of fibrillin-1 perturbation.Transforming Growth Factor-β1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome.Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes.Relationship between serum adipsin and first-phase of glucose-stimulated insulin secretion in subjects with different glucose tolerance.The Role of Signal Transducer and Activator of Transcription 5 and Transforming Growth Factor-Beta 1 in Hepatic Fibrosis Induced by Chronic Hepatitis C Virus Infection in Egyptian Patients.Toward an early marker of metabolic dysfunction: omentin-1 in prepubertal children.TGF-β1 content in atherosclerotic plaques, TGF-β1 serum concentrations and incident coronary events
P2860
Q24630117-0B028D32-79AC-4201-B315-48191B584208Q28661191-8E6C00DF-8431-45AB-9073-FDA83CCEE432Q33646736-8D3767C4-0632-4094-9D39-240AB7B290A3Q33932928-008C6C36-B7F3-492C-AB16-524E101B75D8Q34001116-3718190F-05A0-4FD3-B87A-9CD4AFF1D7B9Q34024355-92C59B89-991A-40AD-B637-0BD9F20EB62EQ34086652-863E249B-31FC-4BC1-9ECE-006D806CF2ACQ34199515-934654AE-459E-4279-8FB8-B7D50B4F50A9Q34545454-A9F983B0-7747-449A-A51E-C1095C8DCA40Q34798852-FE6A1C03-09EA-44D3-9162-8ECD9AA6B37EQ34950622-A76CC8A7-64F3-4178-BC81-F9287DE7CFB5Q35165204-A81AF40B-DA7E-4DD5-B2D2-2F77562120C7Q35834745-98BAF76E-CB7C-483E-B36A-D52655989EBAQ36584492-D02839E5-9C6F-4B28-B7A1-55FF751F00F8Q37199783-184B00C8-F7A3-481A-884F-23A080447BE1Q37335279-23B88D23-BE2B-494D-BFA8-854D3329AFE6Q37710090-AE8B8231-7B34-4370-AE19-4E58CE15B8B4Q38888587-2E370203-4773-4239-84C8-BE18790DE86AQ38971326-516B3B25-3182-4DD1-8856-08BCF1623581Q41483284-913ABAA8-D9D1-4599-99DA-8B4616458C6AQ41811073-EEE55F15-930B-4793-96E6-5C82B4F6B35BQ45396344-CA37F8A7-F819-4845-9E1B-366407618462Q50061325-5447368E-523C-4985-8E3A-2E53B9D9E340Q50198283-54238C71-F8D2-4B62-B09E-4907149BC35DQ51371275-1ED1D682-2E5C-4535-A3C3-2FD37C22B258Q57414509-5E540B3C-B2BA-48FD-B753-F18001D0F7FD
P2860
Transforming growth factor-beta1 and incident type 2 diabetes: results from the MONICA/KORA case-cohort study, 1984-2002.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transforming growth factor-bet ...... case-cohort study, 1984-2002.
@en
Transforming growth factor-bet ...... case-cohort study, 1984-2002.
@nl
type
label
Transforming growth factor-bet ...... case-cohort study, 1984-2002.
@en
Transforming growth factor-bet ...... case-cohort study, 1984-2002.
@nl
prefLabel
Transforming growth factor-bet ...... case-cohort study, 1984-2002.
@en
Transforming growth factor-bet ...... case-cohort study, 1984-2002.
@nl
P2093
P2860
P50
P356
P1433
P1476
Transforming growth factor-bet ...... case-cohort study, 1984-2002.
@en
P2093
Astrid Zierer
Christian Herder
Michael Roden
P2860
P304
P356
10.2337/DC09-0476
P407
P577
2009-07-10T00:00:00Z